Angiotensin receptor blockers in heart failure: meta-analysis of randomized controlled trials
Authors:
- Catherine DemersCDCatherine Demers
- Robert S McKelvieRMRobert S McKelvie
- Peter P LiuPLPeter P Liu
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Meta-analysis of observed mortality data from all-controlled, double-blind, multiple-dose studies of losartan in heart failureThe American Journal of Cardiology, 2000
- Candesartan in heart failure—assessment of reduction in mortality and morbidity (CHARM): Rationale and designJournal of Cardiac Failure, 1999
- Contemporary management of patients with left ventricular systolic dysfunction. Results from the Study of Patients Intolerant of Converting Enzyme Inhibitors (SPICE) RegistryEuropean Heart Journal, 1999
- Comparison of the effects of losartan and captopril on mortality in patients after acute myocardial infarction: the OPTIMAAL trial designThe American Journal of Cardiology, 1999
- Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors.Journal of Clinical Investigation, 1997
- Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)The Lancet, 1997
- Bias in the one‐step method for pooling study resultsStatistics in Medicine, 1990
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Beta blockade during and after myocardial infarction: An overview of the randomized trialsProgress in Cardiovascular Diseases, 1985